Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2537551 | European Journal of Pharmacology | 2006 | 4 Pages |
Abstract
Bupropion is a non-nicotinic drug used in smoking cessation therapy. However, its acute effects remain unclear. In this study, we investigated the effects of bupropion on hemodynamic parameters in pentobarbital-anesthetized mongrel dogs. Bupropion administered either in bolus injections (3 or 6 mg/kg, i.v.) or in cumulative doses of 0.01, 0.1, 1, 3 and 10 mg/kg showed, in both studies, a significant increase of mean pulmonary arterial pressure and pulmonary vascular resistance index. These results show that bupropion can elevate the pulmonary pressure. Further investigations should be done to test this effect in smokers with chronic obstructive pulmonary disease.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Maria Ondina Paganelli, José Eduardo Tanus-Santos, Maricene Sabha, Joaquim Francisco do Prado, Marco Vinicíus Chaud, Luís Cláudio Martins, Heitor Moreno Jr.,